Adjunctive oxycodone for the treatment of refractory bipolar depression.
Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California, USA. jschiffman@mednet.ucla.edu
Jason E
JE
Schiffman
Michael J
MJ
Gitlin
D000203:Activities of Daily Living / Q000523:psychology; D000339:Affect / Q000187:drug effects; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D009294:Narcotics / Q000009:adverse effects / Q000627:therapeutic use*; D010098:Oxycodone / Q000009:adverse effects / Q000627:therapeutic use*; D012008:Recurrence
D000928:Antidepressive Agents; D009294:Narcotics; D010098:Oxycodone